Published in Cancer Control on January 01, 2007
Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol (2009) 0.94
Geriatric oncology research to improve clinical care. Nat Rev Clin Oncol (2012) 0.87
Clinical pharmacology of chemotherapy agents in older people with cancer. Curr Gerontol Geriatr Res (2011) 0.83
Challenges of managing elderly men with prostate cancer. Nat Rev Clin Oncol (2014) 0.77
Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional age. Oncologist (2014) 0.77
Polypharmacy in older adults: the role of the advanced practitioner in oncology. J Adv Pract Oncol (2013) 0.75
Challenge of cancer in the elderly. ESMO Open (2016) 0.75
Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study. J Thorac Oncol (2008) 0.75
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol (2011) 4.07
Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. J Clin Oncol (2012) 2.48
Has demand for clinical trial participants outpaced supply? J Natl Cancer Inst (2007) 1.39
Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice. J Am Geriatr Soc (2007) 1.35
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes. J Geriatr Oncol (2013) 1.16
Distress in older patients with cancer. J Clin Oncol (2009) 1.13
Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101. J Clin Oncol (2007) 1.11
Chemotherapy options and outcomes in older adult patients with colorectal cancer. Crit Rev Oncol Hematol (2009) 1.06
Unusual abdominal tumors, case 1. Pseudomyxoma peritonei: response to capecitabine. J Clin Oncol (2004) 0.97
Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment. J Am Geriatr Soc (2014) 0.97
NCCN Task Force Report: breast cancer in the older woman. J Natl Compr Canc Netw (2008) 0.96
Geriatric oncology: an overview. J Clin Oncol (2014) 0.96
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy. Gynecol Oncol (2007) 0.94
Toxicity of bevacizumab in combination with chemotherapy in older patients. Oncologist (2013) 0.90
Breast and ovarian cancer in the older woman. J Clin Oncol (2014) 0.88
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer. Gynecol Oncol (2011) 0.87
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment. Gynecol Oncol (2009) 0.85
Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer. Drugs Aging (2002) 0.85
Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly. Oncologist (2005) 0.83
Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763. Clin Cancer Res (2004) 0.81
Call for changes in clinical trial reporting of older patients with cancer. J Clin Oncol (2012) 0.80
Ovarian cancer in older women. Semin Oncol (2008) 0.80
Use of complementary medications among older adults with cancer. Cancer (2012) 0.79
Chemotherapy for the elderly patient with colorectal cancer. Cancer J (2010) 0.79
Management of the elderly patient with gynecologic cancer: report of the 2011 workshop in geriatric gynecologic oncology. Int J Gynecol Cancer (2012) 0.79
Doublet chemotherapy in the elderly patient with ovarian cancer. Oncologist (2012) 0.78
Effect of age on drug metabolism in women with breast cancer. Expert Opin Drug Metab Toxicol (2015) 0.78
Treatment of elderly cancer patients with chemotherapy. Cancer Invest (2005) 0.78
CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer. Int J Gynecol Cancer (2013) 0.77
Management of colorectal cancer in older patients. Oncology (Williston Park) (2006) 0.76
Senior adult oncology: three cases of advanced cancer in patients of advanced age. Semin Oncol (2012) 0.75
Resection of colorectal liver metastases: only for younger patients? Lancet Oncol (2010) 0.75
Reply to L.K. Mell et al. J Clin Oncol (2014) 0.75
Treatment of advanced lung cancer in the elderly. Hosp Pract (1995) (2011) 0.75
Care of elderly women with ovarian cancer. Geriatr Nurs (2004) 0.75
Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis. Int J Gynecol Pathol (2016) 0.75
A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabine. Cancer Invest (2007) 0.75
Unusual uterine recurrence of primary central nervous system lymphoma. Clin Adv Hematol Oncol (2006) 0.75